Jeffrey Wilken

1.6k total citations
51 papers, 1.1k citations indexed

About

Jeffrey Wilken is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Jeffrey Wilken has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 10 papers in Psychiatry and Mental health and 9 papers in Neurology. Recurrent topics in Jeffrey Wilken's work include Multiple Sclerosis Research Studies (31 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Olfactory and Sensory Function Studies (7 papers). Jeffrey Wilken is often cited by papers focused on Multiple Sclerosis Research Studies (31 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Olfactory and Sensory Function Studies (7 papers). Jeffrey Wilken collaborates with scholars based in United States, Israel and Canada. Jeffrey Wilken's co-authors include Robert L Kane, Mitchell T. Wallin, Robert R. Kane, Robert Berkowitz, Mark Gudesblatt, Marijean Buhse, Michael Kabat, Tresa Roebuck‐Spencer, Daniel Golan and Glen M. Doniger and has published in prestigious journals such as Neurology, Journal of Allergy and Clinical Immunology and Experimental Brain Research.

In The Last Decade

Jeffrey Wilken

49 papers receiving 1.1k citations

Peers

Jeffrey Wilken
Cavit Boz Türkiye
Simone Kern Germany
Yair Morad Israel
Joseph Guarnaccia United States
A. Romani Italy
Sabrina Realmuto Italy
Rosalind Kandler United Kingdom
Holly James Westervelt United States
Dominic A. Carone United States
Colin R. Bamford United States
Cavit Boz Türkiye
Jeffrey Wilken
Citations per year, relative to Jeffrey Wilken Jeffrey Wilken (= 1×) peers Cavit Boz

Countries citing papers authored by Jeffrey Wilken

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Wilken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Wilken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Wilken more than expected).

Fields of papers citing papers by Jeffrey Wilken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Wilken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Wilken. The network helps show where Jeffrey Wilken may publish in the future.

Co-authorship network of co-authors of Jeffrey Wilken

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Wilken. A scholar is included among the top collaborators of Jeffrey Wilken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Wilken. Jeffrey Wilken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogaardt, Hans, Daniel Golan, Jeffrey Wilken, et al.. (2024). Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions. Multiple Sclerosis and Related Disorders. 88. 105696–105696. 4 indexed citations
2.
Attarian, Hrayr, Marijean Buhse, Daniel Golan, et al.. (2023). Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters. International Journal of MS Care. 26(2). 57–60. 3 indexed citations
3.
Bogaardt, Hans, Daniel Golan, Stacie Attrill, et al.. (2023). Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?. Multiple Sclerosis and Related Disorders. 73. 104630–104630. 10 indexed citations
4.
Wilken, Jeffrey, Anthony Traboulsee, Flavia Nelson, et al.. (2023). Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results. Multiple Sclerosis and Related Disorders. 73. 104677–104677. 5 indexed citations
5.
6.
Cutter, Gary, Daniel Golan, Glen M. Doniger, et al.. (2022). Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient. Multiple Sclerosis and Related Disorders. 60. 103704–103704. 12 indexed citations
7.
Covey, Thomas J., Daniel Golan, Glen M. Doniger, et al.. (2022). Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis. Clinical Neurophysiology. 137. 66–74. 5 indexed citations
8.
Wilken, Jeffrey, Marijean Buhse, Iris‐Katharina Penner, et al.. (2022). Cognitive impairment in people with multiple sclerosis: Perception vs. performance – factors that drive perception of impairment differ for patients and clinicians. Multiple Sclerosis and Related Disorders. 69. 104410–104410. 7 indexed citations
9.
Covey, Thomas J., Daniel Golan, Glen M. Doniger, et al.. (2022). Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 67. 104073–104073. 1 indexed citations
10.
Zanotto, Tobia, Jacob J. Sosnoff, Edward Ofori, et al.. (2022). Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis. Multiple Sclerosis and Related Disorders. 59. 103645–103645. 10 indexed citations
11.
Covey, Thomas J., Daniel Golan, Glen M. Doniger, et al.. (2021). The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103349–103349. 7 indexed citations
12.
Golan, Daniel, Glen M. Doniger, Diana M. Sima, et al.. (2020). The association between MRI brain volumes and computerized cognitive scores of people with multiple sclerosis. Brain and Cognition. 145. 105614–105614. 13 indexed citations
13.
Golan, Daniel, Mark Gudesblatt, Lori Fafard, et al.. (2018). Baseline cognitive function of patients with relapsing remitting multiple sclerosis is associated with therapeutic response to Natalizumab (P6.348). Neurology. 90(15_supplement). 1 indexed citations
14.
Gudesblatt, Mark, Lori Fafard, Jeffrey Wilken, et al.. (2018). Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis. CNS Drugs. 32(12). 1173–1181. 15 indexed citations
15.
Erlanger, David M., Tanya Kaushik, Lauren Caruso, et al.. (2014). Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial. Journal of the Neurological Sciences. 340(1-2). 123–129. 29 indexed citations
16.
Wilken, Jeffrey, Robert L Kane, Mark Gudesblatt, et al.. (2013). Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab. International Journal of MS Care. 15(3). 120–128. 33 indexed citations
17.
Wilken, Jeffrey, et al.. (2007). Recognizing and Treating Common Psychiatric Disorders in Multiple Sclerosis. The Neurologist. 13(6). 343–354. 17 indexed citations
18.
Wallin, Mitchell T., Jeffrey Wilken, Aaron P. Turner, Rhonda M. Williams, & Robert L Kane. (2006). Depression and multiple sclerosis: Review of a lethal combination. The Journal of Rehabilitation Research and Development. 43(1). 45–45. 79 indexed citations
19.
Frohman, Elliot M., Massimo Filippi, Olaf Stüve, et al.. (2005). Characterizing the Mechanisms of Progression in Multiple Sclerosis. Archives of Neurology. 62(9). 1345–1345. 83 indexed citations
20.
Wilken, Jeffrey, et al.. (1999). Anxiety and arousal: tests of a new six-system model. International Journal of Psychophysiology. 33(3). 197–207. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cavit Boz Breakdown of academic impact, for papers by Simone Kern Breakdown of academic impact, for papers by Yair Morad Breakdown of academic impact, for papers by Joseph Guarnaccia Breakdown of academic impact, for papers by A. Romani Breakdown of academic impact, for papers by Sabrina Realmuto Breakdown of academic impact, for papers by Rosalind Kandler Breakdown of academic impact, for papers by Holly James Westervelt Breakdown of academic impact, for papers by Dominic A. Carone Breakdown of academic impact, for papers by Colin R. Bamford
Rankless by CCL
2026